Vimodeghi

Related products

• 

  Breast cancer , Renal cell carcinoma (RCC)

  Sorafenib

  【Product name】NEXAVAR

  [English common name]Sorafenib

  [Chinese common name]Sorafenib

  [English name]

  [Chinese other name]Solafini, sorafini monomer

  [indications]
  Sorafenib: TYKERB lapatinib is used in combination with capecitabine to treat ErbB-2 overexpression and has previously received advanced or metastatic treatments including anthracyclines, paclitaxel, and trastuzumab (Herceptin). SexBreast cancer.
  Sorafenib tosylate tablets: treatment of advanced surgeryRenal cell carcinoma.
  Nexavar (Sorafenib): Sorafenib has been approved for the treatment of advanced renal cell carcinoma (the most common type of kidney cancer). In addition, there are currently nearly 50 clinical trials in the world that use sorafenib to treat a variety of other cancers.

  【Dosage】
  Sorafenib: The recommended dose is 1250 mg, once a day, on days 1 to 21, with capecitabine 2000 mg/d, and on the first to 14 days in 2 divided doses. Lapatinib should be taken once a day. It is not recommended to take it in divided doses. Take 1 h before meals or 2 h after meals. If one dose is missed, the dose will not be doubled on the second day. Pregnancy level D, pregnant women are banned. It is unclear whether milk secretion is passed, and lactating women should stop breastfeeding. There were no significant differences between the elderly and young patients. Patients with severe kidney damage and dialysis have not been clinically tested, and patients with moderate to severe liver damage should be given a dose reduction.
  Sorafenib tosylate tablets:
  Recommended Dosage: It is recommended to take sorafenib for 0.4 g (2 x 0.2 g) each time, twice daily, on an empty stomach or with a low-fat, medium-fat diet.
  How to use: Oral, swallow with a cup of warm water.
  Treatment time: The treatment should be continued until the patient is unable to clinically benefit or tolerate the toxic reaction.
  Nexavar (Sorafenib): Patients should read the product instructions and patient instructions carefully before taking the drug. Patients should be advised to take effective contraception during the medication and to try to conceive after at least 2 weeks of discontinuation. Inform patients to take the medicine on an empty stomach. If the patient forgets to take the medicine, there is no need to increase the dose for the next dose. When the patient has a rash on the hands and feet during the medication, he should contact the doctor for treatment accordingly.

  [Storage]
  Sorafenib tosylate tablets: Store at a temperature below 25 ° C. Keep the drug out of the reach of children.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Renal cell carcinoma (RCC) , Gastrointestinal stromal tumor (GIST)

  Sunitinib

  【Product name】Sutent

  [English common name]Sunitinib

  [Chinese common name]Sunitinib

  [English name]

  [Chinese other name]Sunitinib, sulindini base, sunitinib base

  [Indications] ImatinibGastrointestinal stromal tumorKidney resectable or metastaticRenal cell carcinoma, pancreatic neuroendocrine tumors.

  [Usage and Dosage] Imatinib resistant gastrointestinal stromal tumors, radical resectable or metastatic renal cell carcinoma adults, oral 50mg once a day, oral sunitinib for 4 weeks, and then discontinued for 2 weeks. In addition, the weight is reduced according to the condition of the patient. In adults with pancreatic neuroendocrine tumors, sunitinib is orally administered 37.5 mg daily. Depending on the condition of the patient, it may be increased or decreased as appropriate, but may be increased to 50 mg per day.

  [Storage] 2-8 degrees Celsius, protected from light and moisture, sealed and dry.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Renal cell carcinoma (RCC)

  Axitinib

  【Product name】Inlyta

  [English common name]Axitinib

  [Chinese common name]Axitinib

  [English name]

  [Chinese other name] axitinib

  [Indications] as a second-line drug for non-responsive to initial therapyRenal cell carcinomaTreatment of the patient.

  【Dosage】The initial oral dose recommended by axitinib is 5 mg (twice daily). Axitinib can be administered with food or under fasting conditions, with a daily interval of approximately 12 hours (see [Pharmacokinetics]). Apply a cup of water to azizinib.

  [Storage]Store at 20 ° C ~ 25 ° C. Allow short-term storage at 15 ° C ~ 30 ° C.

  【Tips】Part of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctor's face diagnosis. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.